
Cogent Biosciences is a biotechnology business based in the US. Cogent Biosciences shares (COGT) are listed on the NASDAQ and all prices are listed in US Dollars. Cogent Biosciences employs 121 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Cogent Biosciences stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – COGT. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Cogent Biosciences stock price (NASDAQ: COGT)
Use our graph to track the performance of COGT stocks over time.Cogent Biosciences shares at a glance
Latest market close | $14.84 |
---|---|
52-week range | $3.79 - $18.07 |
50-day moving average | $11.75 |
200-day moving average | $11.08 |
Wall St. target price | $22.14 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.21 |
Buy Cogent Biosciences stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Cogent Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cogent Biosciences price performance over time
Historical closes compared with the close of $14.84 from 2023-01-25
1 week (2023-01-20) | 10.66% |
---|---|
1 month (2022-12-27) | 37.66% |
3 months (2022-10-27) | 9.93% |
6 months (2022-07-27) | 32.97% |
1 year (2022-01-23) | N/A |
---|---|
2 years (2021-01-27) | 54.58% |
3 years (2020-01-27) | 1,414.44% |
5 years (2018-01-23) | N/A |
Cogent Biosciences financials
Gross profit TTM | $-55,913,000 |
---|---|
Return on assets TTM | -29.65% |
Return on equity TTM | -51.54% |
Profit margin | 0% |
Book value | $3.21 |
Market capitalisation | $880.7 million |
TTM: trailing 12 months
Cogent Biosciences share dividends
We're not expecting Cogent Biosciences to pay a dividend over the next 12 months.
Have Cogent Biosciences's shares ever split?
Cogent Biosciences's shares were split on a 1:4 basis on 9 November 2020. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cogent Biosciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Cogent Biosciences shares which in turn could have impacted Cogent Biosciences's share price.
Cogent Biosciences share price volatility
Over the last 12 months, Cogent Biosciences's shares have ranged in value from as little as $3.79 up to $18.07. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cogent Biosciences's is -0.5813. This would suggest that Cogent Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cogent Biosciences has bucked the trend.
Cogent Biosciences overview
Cogent Biosciences, Inc. , a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc.
Cogent Biosciences in the news
14 Small-Cap Stocks with High Potential
Companies Like Cogent Biosciences (NASDAQ:COGT) Are In A Position To Invest In Growth
Cogent Biosciences Announces Planned 2023 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Cancer Therapeutics
Frequently asked questions
What percentage of Cogent Biosciences is owned by insiders or institutions?Currently 0.007% of Cogent Biosciences shares are held by insiders and 110.14% by institutions. How many people work for Cogent Biosciences?
Latest data suggests 121 work at Cogent Biosciences. When does the fiscal year end for Cogent Biosciences?
Cogent Biosciences's fiscal year ends in December. Where is Cogent Biosciences based?
Cogent Biosciences's address is: 200 Cambridge Park Drive, Cambridge, MA, United States, 02140 What is Cogent Biosciences's ISIN number?
Cogent Biosciences's international securities identification number is: US19240Q2012
More guides on Finder
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
-
Best international stock brokers for 2023
We explore some of the best brokerage accounts for international stock trading. Here’s what you need to know.
Ask an Expert